Prevalite Alternatives Compared
Prevalite (cholestyramine) | Fenofibrate | Atorvastatin |
|
---|
Prevalite (cholestyramine) | Fenofibrate | Atorvastatin |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Pruritus of Partial Biliary Obstruction, Hyperlipoproteinemia Type IIb - Elevated LDL VLDL, Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa - Elevated LDL. Prevalite may also be... View more |
Prescription only
Fenofibrate is effective at reducing triglyceride levels and increasing HDL cholesterol levels; however, it is less effective than statins at reducing LDL cholesterol levels. Fenofibrate tablets... View more |
Prescription only
Atorvastatin is effective at lowering cholesterol; however, its use may be limited by side effects such as muscle pain. Prescribed for High Cholesterol, High Cholesterol - Familial Homozygous, High... View more |
Related suggestions Hyperlipoproteinemia
Hyperlipoproteinemia Type IIa, Elevated LDL
Hyperlipoproteinemia Type IIb, Elevated LDL VLDL
|
|||||||||||||||||||||||
More about Prevalite (cholestyramine) | More about Fenofibrate | More about Atorvastatin | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Prevalite has an average rating of 7.5 out of 10 from a total of 4 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 0% reported a negative effect. |
Fenofibrate has an average rating of 5.7 out of 10 from a total of 69 ratings on Drugs.com. 43% of reviewers reported a positive effect, while 38% reported a negative effect. |
Atorvastatin has an average rating of 4.3 out of 10 from a total of 299 ratings on Drugs.com. 28% of reviewers reported a positive effect, while 54% reported a negative effect. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Prevalite side effects |
View all Fenofibrate side effects |
View all Atorvastatin side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
N/A |
Lower cost generic |
Lower cost generic |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Prevalite prices |
View all Fenofibrate prices |
View all Atorvastatin prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other cholestyramine brands include: Cholestyramine Light | Antara, Fenoglide, Lipofen, TriCor, Triglide | Atorvaliq, Lipitor | ||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
2 hours |
20 hours |
14 hours |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 137 drugs are known to interact with Prevalite:
|
A total of 146 drugs are known to interact with Fenofibrate:
|
A total of 402 drugs are known to interact with Atorvastatin:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
December 31, 1993 |
December 17, 1996 |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.